1-1 of 1
Hoyoung Kim, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicenter Phase II Trial of Etoposide, Methylprednisolone, High-Dose Cytarabine, and Oxaliplatin (ESHAOx) for Patients with Refractory/Relapsed Aggressive Non-Hodgkin’s Lymphoma.

Sun Jin Sym, MD, Hye Jin Kang, M.D., Seung-Hyun Nam, M.D., Hoyoung Kim, M.D., Seok Jin Kim, M.D., Hyeon Seok Eom, M.D., Won Seog Kim, M.D., Cheolwon Suh, M.D.
Journal: Blood
Blood (2007) 110 (11): 3446.
https://doi.org/10.1182/blood.V110.11.3446.3446
Published: 2007